Professor Christopher Griffiths (BSc, MB, BS, MD,FRCP,FRCP(Edin), FRCPath, FMedSci) - personal details
Chris Griffiths gained a 1st class hons BSc in Anatomy and qualified in Medicine from St Thomas’ Hospital Medical School, London University. He trained in Dermatology at St Mary’s Hospital, London, and at the University of Michigan, USA, where he was also on Faculty for 4 years. He was appointed to the Foundation Chair in Dermatology at the University of Manchester in 1994 and is an honorary consultant dermatologist at Salford Royal NHS Foundation Trust. Professor Griffiths developed the ‘hub-and-spoke’ model of dermatology services for Greater Manchester, and introduced a multidisciplinary clinic for severe psoriasis – the Manchester Psoriasis Service – awarded Hospital Doctor Dermatology Team of the Year in 2002. At the University of Manchester he has served variously as: Head of Medicine and Neuroscience; Head of the School of Translational Medicine; Associate Dean for Research and; Director of the Manchester Academic Health Science Centre.
Professor Griffiths’ named lectureships include: Sydney Watson Smith (2006); Parkes Weber (2007); Von Zumbusch, Munich (2008) and; Hellerstrom, Stockholm (2010). He is co-founder of the International Psoriasis Council and is its President-Elect. He received the psoriasis lifetime achievement award of the American Skin Association in 2009. The Times of London named him as one of the UK’s Top 200 doctors in 2010 and in 2011 he was appointed as an NIHR Senior Investigator and elected to Fellowship of the Academy of Medical Sciences.
Professor Griffiths has been President of :the British Association of Dermatologists (2004-5); European Dermatology Forum (2010-11) and; British Society for Investigative Dermatology (1997-2000). He serves on the editorial boards of eight scientific journals and is an Associate Editor of the Journal of Investigative Dermatology. He has published 458 Pubmed cited articles in scientific journals, has an H-Index of 73 and is lead editor of Rook’s Textbook of Dermatology. His research includes immunological mechanisms of psoriasis, where he has been instrumental in development of the new biologics, immunotherapy (including the new biological agents), the “brain-skin axis” and mechanisms and repair of skin ageing, particularly topical retinoids.